Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Brines

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Molecular Medicine (Cambridge, Mass.)|December 31, 2014
Discovery of a master regulator of injury and healing: tipping the outcome from damage toward repairMichael Brines
Oncology (Williston Park, N.Y.)|October 17, 2002
What evidence supports use of erythropoietin as a novel neurotherapeutic?Michael Brines
Blood Purification|January 23, 2010
The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptorsMichael Brines
Nature Reviews. Neuroscience|June 2, 2005
Emerging biological roles for erythropoietin in the nervous systemMichael Brines, Anthony Cerami
Clinical Breast Cancer|January 21, 2003
Recombinant human erythropoietin for neuroprotection: what is the evidence?Tore Eid, Michael Brines
Molecular Medicine (Cambridge, Mass.)|December 21, 2011
The receptor that tames the innate immune responseMichael Brines, Anthony Cerami
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2013
Erythropoietin and engineered innate repair activatorsMichael Brines, Anthony Cerami
Critical Care (London, England)|October 8, 2004
Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?Thomas Coleman, Michael Brines
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 5, 2010
Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Carla Cerami Hand, Michael Brines
Cells|October 23, 2021
Neurons Are a Primary Driver of Inflammation via Release of HMGB1Huan Yang, Ulf Andersson, Michael Brines
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Molecular Medicine (Cambridge, Mass.)|December 31, 2014
Discovery of a master regulator of injury and healing: tipping the outcome from damage toward repairMichael Brines
Oncology (Williston Park, N.Y.)|October 17, 2002
What evidence supports use of erythropoietin as a novel neurotherapeutic?Michael Brines
Blood Purification|January 23, 2010
The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptorsMichael Brines
Nature Reviews. Neuroscience|June 2, 2005
Emerging biological roles for erythropoietin in the nervous systemMichael Brines, Anthony Cerami
Clinical Breast Cancer|January 21, 2003
Recombinant human erythropoietin for neuroprotection: what is the evidence?Tore Eid, Michael Brines
Molecular Medicine (Cambridge, Mass.)|December 21, 2011
The receptor that tames the innate immune responseMichael Brines, Anthony Cerami
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2013
Erythropoietin and engineered innate repair activatorsMichael Brines, Anthony Cerami
Critical Care (London, England)|October 8, 2004
Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?Thomas Coleman, Michael Brines
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 5, 2010
Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Carla Cerami Hand, Michael Brines
Cells|October 23, 2021
Neurons Are a Primary Driver of Inflammation via Release of HMGB1Huan Yang, Ulf Andersson, Michael Brines
Pageof 12